Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic

W Daoud BenAmor,A Labella,H Moalla Frikha,L Martínez López
DOI: https://doi.org/10.1016/j.ifacol.2022.10.035
Abstract:The global health products supply chain is negatively influenced by the COVID-19 pandemic. Moreover, the risks in the pharmaceutical supply chain (PSC) have increased. Assessment and mitigation risks in PSC are essential issues to control and counter these risks. In this study, a 2-Tuple ARAS-BWM approach, which combines ARAS and BWM methods under linguistic 2-Tuple environment, is proposed to evaluate and address various risks to the best mitigation strategies in the pharmaceutical industry in Tunisia during COVID-19. Noted that the main risk identified in the PSC is related to supply and suppliers and its best mitigation strategy is reducing risk.
What problem does this paper attempt to address?